Study identifies ways to increase IUD use in developing countries

February 15, 2013 by Michelle L. Brandt, Stanford University Medical Center

Boosting demand for intrauterine devices, commonly referred to as IUDs, and improving access to them can significantly increase their use in developing countries, where they have traditionally been an unpopular method of birth control, a new study says.

Researchers at the nonprofit Population Services International and the Stanford University School of Medicine show how they were able to provide these long-acting, reversible contraceptives to more than a half-million women in 13 countries.

The group's "experience with promoting a previously believed to be unsuitable for these contexts should encourage both public and private providers," the researchers wrote in their paper, which appears in this month's issue of Contraception.

Paul Blumenthal, MD, professor of and director of the Stanford Program for International Reproductive Education and Services, is the study's lead author. The other authors are with PSI, a Washington, DC-based organization dedicated to improving the health of people in the .

Long-acting reversible contraceptives, such as IUDs, are known to be a safe, effective and inexpensive form of birth control. The IUD does not have widespread popularity, though: A 2005 United Nations report showed that IUDs were used by 7.6 percent of women of reproductive age in developing countries, compared to 14.5 percent of women in developed ones.

Experts believe there are a variety of factors that prevent more women in from using IUDs. Among others are "myths and rumors about the IUD, uncertainty or inadequate information about where a woman could get one, and an inadequate number of providers trained and ready to provide a quality service," Blumenthal said.

Women in these countries may face hurdles with other forms of birth control, as well. Access is common problem. "Clients often have to go a long distance to get their method, and even then might get to the clinic only to find out it's out of stock," said Blumenthal.

Project director Dana Tilson added, "When contraceptives are available in these settings, they are often limited to one or two options, all requiring frequent, repeat visits to continue."

In an effort to, in Tilson's words, "give women access to a range of choices that were previously unavailable" and to improve reproductive health, the researchers launched a two-year, 13-country initiative to promote and provide IUDs.

The project began in 2009 and focused on Cambodia, El Salvador, Guatemala, India, Kenya, Madagascar, Myanmar, Nepal, Nicaragua, Nigeria, Uganda, Tanzania and Zambia. The countries were chosen, Blumenthal said, because of their low IUD usage numbers, and because PSI identified them as areas with opportunities for significant improvement.

The initiative focused on both creating demand and improving service delivery. A group of community "mobilizers" conducted outreach in many of the countries, going door to door or arranging group meetings to educate women on family planning options and linking them with local providers. Media activities, including radio and TV spots, printed educational materials and billboards, were also done in many areas to address misconceptions about and to educate women on the potential benefits of using them.

Project leaders also improved access by training local clinic staff on counseling, complication management, side effects, removals and referrals, and by offering IUD insertion at a variety of clinics throughout each of the countries. Outreach clinic event days were held in six countries, during which IUD insertions were offered to local women over a one- to three-day period.

Between January 2009 and December 2010, 575,601 women across the 13 countries were provided with IUDs. The typical woman who received an IUD was in her 20s, married, had at least one living child and was primary-school educated. Twenty-four percent of women who received an IUD said they previously had been using no modern birth-control method.

Blumenthal believes a "success at this scale has not been previously reported." And he and his colleagues noted in the paper that the fact that so many women opted for an IUD indicates increased use is likely to occur "once barriers of provider training and negative perceptions of IUDS are overcome."

The authors also emphasized the importance of linking demand creation and service delivery. "By creating demand through 'marketing' but then also ensuring that there's a high-quality, reliable provider within easy reach of the client, we have shown that IUDs can be acceptable to women and provided at scale," said Blumenthal.

This initiative is ongoing, with the number of countries being expanded. Project leaders are now refining marketing approaches, focusing on providing IUDs to women immediately after they have delivered a baby, and working with various ministries of health to revise outdated guidelines, which will make access easier for women. Project directors are also turning their attention to post-abortion care, aiding women who have experienced unsafe abortions and ensuring they have access to contraception.

Explore further: Immediate use of an IUD following abortion more likely to prevent unintended pregnancies

Related Stories

Immediate use of an IUD following abortion more likely to prevent unintended pregnancies

June 8, 2011
Women who receive a contraceptive known as an intrauterine device or IUD immediately following a first trimester abortion experience few complications and are less likely to have an unintended pregnancy than those who delay ...

Long-acting contraception methods reduce repeat abortions

July 25, 2011
Repeat abortions are significantly reduced if women use long-acting reversible contraceptive methods such as intrauterine devices (IUDs) after an abortion.

Consider IUDs for contraception, other conditions

April 13, 2012
Researchers at the University of Cincinnati (UC) have found that intrauterine devices (IUDs) containing progesterone are a safe and effective means of birth control and support its use as a treatment option for medical conditions ...

Recommended for you

Essure female sterilization device appears safe: study

January 23, 2018
(HealthDay)—Essure implants used in female sterilization have come under fire in recent years, with women reporting a wide array of problems to the U.S. Food and Drug Administration.

Premature births linked to changes in mother's bacteria

January 23, 2018
Changes to the communities of microbes living in the reproductive tract of pregnant women could help to spot those at risk of giving birth prematurely.

Study shows how fetal infections may cause adult heart disease

January 23, 2018
Recent studies have shown that infants born prematurely have a higher risk of developing heart disease later in life. Now, a study led by researchers at the University of Washington School of Medicine in Seattle shows that, ...

Rise in preterm births linked to clinical intervention

January 18, 2018
Research at the University of Adelaide shows preterm births in South Australia have increased by 40 percent over 28 years and early intervention by medical professionals has resulted in the majority of the increase.

New report calls into question effectiveness of pregnancy anti-nausea drug

January 17, 2018
Previously unpublished information from the clinical trial that the U.S. Food and Drug Administration relied on to approve the most commonly prescribed medicine for nausea in pregnancy indicates the drug is not effective, ...

New study finds 'baby brain' is real, but the cause remains mysterious

January 15, 2018
So-called "baby brain" refers to increased forgetfulness, inattention, and mental "fogginess" reported by four out of five pregnant women. These changes in brain function during pregnancy have long been recognised in midwifery ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.